Clinical Trial

GABA Biomarkers in Dravet Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 14, 2022 (before its estimated September 8, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study will non-invasively obtain levels of GABA in the brain of children with SCN1A+DS and neurodeveloping children through evoked and induced cortical responses, correlate them with the BOLD responses, and with the levels of GABA in their blood.
Trial Details
NCT Number NCT05651204
Lead Sponsor Cook Children's Health Care System
Collaborators: Encoded Therapeutics
Conditions Dravet Syndrome
Enrollment 36 participants
Start Date 2022-09-08
Primary Completion 2024-09-08 (estimated)
Study Completion 2027-09-08 (estimated)
Updated on ClinicalTrials.gov 2022-12-14